SCHEMBL25359489

SCHEMBL25359489

C[C@H]1C[C@@]2(CCN1C(=O)O)OCC(F)(F)c1cc(Cl)sc12

nearest known ligand 0.43

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 17/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25359498 1.00 OPRL1 (0.43) OPRL1
SCHEMBL31387368 0.86 OPRL1 (0.39) OPRL1
SCHEMBL26064325 0.86 OPRL1 (0.39) OPRL1
SCHEMBL25357188 0.86 OPRL1 (0.35) OPRL1
SCHEMBL1810594 0.82 OPRL1 (0.49) OPRL1
SCHEMBL25358357 0.80
SCHEMBL25356900 0.80 OPRL1 (0.46) OPRL1
SCHEMBL25359152 0.80 OPRL1 (0.46) OPRL1
SCHEMBL25359821 0.79
SCHEMBL25358396 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154344-A1 2-METHYL-4',5'-DIHYDROSPIRO[PIPERIDINE-4,7'-THIENO[2,3-C]PYRAN] DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-08-17 WO disclosed